Advanced search
Publication Cover
Expert Review of Hematology Volume 8, 2015 - Issue 4
Submit an article Journal homepage
2,568
Views
10
CrossRef citations to date
0
Altmetric
Drug Profile

Recombinant B domain deleted porcine factor VIII for the treatment of bleeding episodes in adults with acquired hemophilia A

Edward GompertsDivision of Hematology-Oncology, Children’s Hospital of Los Angeles, 4650 Sunset Boulevard, Los Angeles, CA 90027, USA
Pages 427-432 | Published online: 30 Apr 2015

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Steven W. Pipe, Gil Gonen-Yaacovi & Oscar G. Segurado. (2022) Hemophilia A gene therapy: current and next-generation approaches. Expert Opinion on Biological Therapy 22:9, pages 1099-1115.
Read now
Jenny Klintman & Erik Berntorp. (2016) Epidemiological aspects of inhibitor development in hemophilia and strategies of management. Expert Opinion on Orphan Drugs 4:2, pages 153-168.
Read now

Articles from other publishers (8)

Yesim Dargaud & Carmen Escuriola‐Ettingshausen. (2021) Recombinant porcine factor VIII: Lessons from the past and place in the management of hemophilia A with inhibitors in 2021. Research and Practice in Thrombosis and Haemostasis 5:8, pages e12631.
Crossref
Patrick Ellsworth, Sheh-Li Chen, Raj S. KasthuriNigel S. Key, Micah J. MooberryAlice D. Ma. (2020) Recombinant porcine FVIII for bleed treatment in acquired hemophilia A: findings from a single-center, 18-patient cohort. Blood Advances 4:24, pages 6240-6249.
Crossref
Halet Türkantoz, Christoph Königs, Paul Knöbl, Robert Klamroth, Katharina Holstein, Angela Huth‐Kühne, Jürgen Heinz, Hermann Eichler & Andreas Tiede. (2020) Cross‐reacting inhibitors against recombinant porcine factor VIII in acquired hemophilia A: Data from the GTH‐AH 01/2010 Study. Journal of Thrombosis and Haemostasis 18:1, pages 36-43.
Crossref
Charles Nakar & Amy Shapiro. (2019) Hemophilia A with inhibitor: Immune tolerance induction (ITI) in the mirror of time. Transfusion and Apheresis Science 58:5, pages 578-589.
Crossref
Janie Charlebois, Georges-Étienne Rivard & Jean St-Louis. (2018) Management of acquired hemophilia A: Review of current evidence. Transfusion and Apheresis Science 57:6, pages 717-720.
Crossref
David Green. 2018. Hemophilia and Von Willebrand Disease. Hemophilia and Von Willebrand Disease 81 96 .
S. E. Croteau, Y. L. Abajas, A. S. Wolberg, B. I. Nielsen, G. R. Marx, C. W. Baird, E. J. Neufeld & P. E. Monahan. (2017) Recombinant porcine factor VIII for high-risk surgery in paediatric congenital haemophilia A with high-titre inhibitor. Haemophilia 23:2, pages e93-e98.
Crossref
Robert A Lazarus & Friedrich Scheiflinger. (2017) Mining ancient proteins for next-generation drugs. Nature Biotechnology 35:1, pages 28-29.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.